MMedXYNews
Ask AIHomeVideos
© 2026 MedXY
Contact usAbout usPrivacy PolicyMedXY story
MedXY News/Clinical Updates

Section

Clinical Updates

1,553 articles

Ask AI
All specialtiesClinical UpdatesnewsCardiologyOncologyDiabetes & Endocrinology

Latest updates

Clinical Updates

Gut Microbiota and Idiopathic Pulmonary Fibrosis: Associations with Disease Severity and Survival Outcomes

Emerging evidence reveals gut microbiota profiles correlate with disease severity and survival in idiopathic pulmonary fibrosis, highlighting potential microbial biomarkers and treatment modifiers.

Oct 11, 2026
Clinical Updates

CGM Versus OGTT in Early-Stage Type 1 Diabetes: Comparative Predictive Accuracy and Clinical Implications

This review synthesizes evidence demonstrating that continuous glucose monitoring (CGM) metrics, particularly time above 140 mg/dL, predict progression to stage 3 type 1 diabetes with accuracy comparable to oral glucose tolerance test (OGTT

Oct 11, 2026
Clinical Updates

Racial and Ethnic Disparities in Treatment Initiation and Survival Among Patients With Endometrial Cancer: Socioeconomic Modifiers and Clinical Implications

This review synthesizes recent evidence demonstrating persistent racial and ethnic disparities in treatment initiation and survival among patients with advanced endometrial cancer, highlighting the critical influence of socioeconomic status

Oct 10, 2026Sign in to read
Cardiology

Dual Antiglutamate Therapy in Super-Refractory Status Epilepticus After Cardiac Arrest: Insights from the SUPER-CAT Study and Current Evidence

This review synthesizes evidence on dual antiglutamate therapy combining AMPA and NMDA receptor blockade in postanoxic super-refractory status epilepticus, highlighting the SUPER-CAT study’s demonstration of improved seizure resolutio

Oct 10, 2026Sign in to read
Clinical Updates

Quantitative Relationship Between Lumipulse G Measures of pTau217 in Plasma and Temporal Cortex Pathology in Alzheimer Disease

Plasma pTau217 levels measured by Lumipulse G assays strongly correlate with postmortem temporal cortex pTau217 pathology, supporting plasma pTau217 as a reliable biomarker for brain tau pathology in Alzheimer disease.

Oct 10, 2026
Clinical Updates

Ten Years of Ocrelizumab in Relapsing Multiple Sclerosis: Insights from the OPERA I and II Randomized Clinical Trials and Related Evidence

Continuous ocrelizumab treatment over 10 years in relapsing MS significantly delays disability progression, reduces relapse rates, and maintains a favorable safety profile, underscoring the clinical benefit of early high-efficacy therapy.

Oct 10, 2026Sign in to read
Clinical Updates

Uterine Fibroids in Latinas: Insights from the Environment, Leiomyomas, Latinas, and Adiposity Study

A prospective cohort study reveals a lower-than-expected prevalence of uterine fibroids among reproductive-aged Latina women in the US, highlighting age-related risk and associations with reproductive factors.

Oct 9, 2026
Clinical Updates

Earlier Disclosure of Blood-Based Biomarkers Enhances Diagnostic Certainty and Clinical Management in Cognitive Disorders: A Review of a Recent Randomized Clinical Trial

Early disclosure of plasma p-tau217 and NfL biomarkers significantly improves diagnostic confidence and clinical decisions in cognitive decline without increasing emotional distress, supporting their integration into routine memory clinic c

Oct 9, 2026
Clinical Updates

Targeting Leukemia Stem Cells in Unfit Acute Myeloid Leukemia with a CD70-Directed Third Agent: Promise and Caveats from the ELEVATE Trial

This review synthesizes evidence from the ELEVATE trial on adding cusatuzumab, a CD70-targeting antibody, to venetoclax with or without azacitidine in unfit AML patients, highlighting therapeutic potential, safety concerns, and translationa

Oct 8, 2026
Clinical Updates

CD25-based Graft-versus-Host Disease Prophylaxis after Haploidentical Hematopoietic Stem Cell Transplantation: Comparative Analysis of Two Prophylactic Regimens

This review synthesizes emerging evidence comparing high-dose anti-CD25 (without methotrexate) versus low-dose anti-CD25 (with methotrexate) strategies for GVHD prophylaxis in haplo-HSCT, highlighting improved acute GVHD control and GRFS wi

Oct 8, 2026
Clinical Updates

Sputum Cellularity and Health Services Utilization in Asthma and COPD: Insights into Inflammatory Phenotypes and Clinical Outcomes

Sputum eosinophilia is linked to increased asthma-specific health services use, while neutrophilic inflammation drives hospitalizations in COPD. Understanding these inflammatory patterns aids personalized management and resource planning.

Oct 8, 2026
Clinical Updates

Clinical Factors Associated With Discordant Plasma P-Tau217 and Established Alzheimer Disease Biomarkers: Implications for Diagnosis and Management

This review synthesizes evidence on clinical and biological factors linked to discordance between plasma p-tau217 and standard AD biomarkers, highlighting implications for diagnosis, patient stratification, and future biomarker development.

Oct 7, 2026
Clinical Updates

Early Optic Nerve Head Swelling Rate Predicts Visual Outcome Deterioration in Nonarteritic Anterior Ischemic Optic Neuropathy: An Evidence-Based Review

Early rapid optic nerve head swelling in NAION correlates with worse visual outcomes, with OCT measures of pONHV and mGCIPL thinning providing prognostic insights within days of symptom onset.

Oct 7, 2026Sign in to read
Clinical Updates

Early Optic Nerve Head Swelling Rate Correlates with Visual Decline in Nonarteritic Anterior Ischemic Optic Neuropathy: An Evidence-Based Review

This review synthesizes longitudinal OCT findings and clinical outcomes in NAION, highlighting the prognostic value of early optic nerve head swelling rates for visual impairment progression, and discusses mechanistic and translational impl

Oct 6, 2026
Clinical Updates

Racial Disparities in Prehospital Interventions Among Injured Patients: An Evidence-Based Review

This review synthesizes evidence on racial disparities in prehospital trauma care, examining intervention rates, the influence of social determinants, and mortality outcomes with a focus on recent cohort data.

Oct 6, 2026
Clinical Updates

Enucleation vs Pancreatoduodenectomy for Benign and Low-Grade Pancreatic Head Tumors: A Contemporary Evidence Synthesis

This review synthesizes current evidence comparing enucleation and pancreatoduodenectomy for benign and low-grade malignant pancreatic head tumors, highlighting differential perioperative risks, long-term quality of life, and tumor-specific

Oct 6, 2026Sign in to read
Clinical Updates

Liver Transplantation for Hepatocellular Carcinoma: Prognostic Impact of Complete Pathologic Response and Influence of Treatment Modality—A US National Database Study

Complete pathologic response (cPR) after locoregional therapies notably improves survival in hepatocellular carcinoma (HCC) patients undergoing liver transplantation. Yttrium-90 radioembolization shows superior cPR rates, particularly when

Oct 6, 2026Sign in to read
Clinical Updates

Beyond the Threshold: Continuous Creatinine Change and Outcomes After Endovascular Thrombectomy for Acute Ischemic Stroke

Early continuous creatinine changes within 48 hours after EVT correlate with graded risks of poor 90-day functional outcome and in-hospital mortality, revealing prognostic nuances beyond traditional dichotomous CA-AKI definitions.

Oct 5, 2026
Clinical Updates

In Utero Exposure to Maternal Diabetes and Its Impact on Offspring Diabetes Risk among First Nations and Non-First Nations Populations: A Comprehensive Review

This review synthesizes evidence linking in utero exposure to preexisting and gestational diabetes with increased diabetes incidence in offspring, highlighting stronger effects among First Nations populations and the mitigating role of peri

Oct 5, 2026
Cardiology

Cardiovascular-Kidney-Metabolic Multimorbidity in Heart Failure: Prevalence, Prognostic Impact, and Clinical Implications Across Ejection Fraction Phenotypes

Most heart failure patients harbor multiple cardiovascular-kidney-metabolic conditions, which independently escalate mortality and readmission risk, especially in HFrEF, underscoring the need for integrated management strategies tailored by

Oct 5, 2026
Previous
12 / 25
1…1011121314…25
Next

Most read

  1. 01Cardiology

    Physical Activity Trajectories Before and After Cardiovascular Disease: Insights from the CARDIA Study

Go deeper with MedXY AI

Explore the evidence behind the news.

Ask AI
MedXY briefing

Stay informed

Medical news and research updates, delivered to your inbox.